Immersive experience and thought leadership forum in Bangkok showcases water, design, and customization are shaping the future of luxury residential and hospitality sectors

BANGKOK, Sept. 28, 2026 /PRNewswire/ — GROHE SPA unveiled Aqua Sanctuary, an immersive installation showcase and thought leadership forum, in the heart of Bangkok. Following critically acclaimed GROHE SPA events and installations in Milan and New York, the brand is driving the conversation with industry leaders from architecture, design, luxury developers, and media on the future of personalized luxury through curated water-centric design and wellbeing.

Demand for personalized wellbeing experiences is growing substantially across the Asia Pacific. Water is increasingly a key medium in delivering differentiated luxury experiences for discerning homeowners and commercial value for developers. GROHE SPA is enabling designers to shape the future of luxury with customizable offerings and solutions in the finest materials and finishes.

The GROHE SPA Aqua Sanctuary exemplifies these future possibilities as an experiential journey, transforming the iconic Nai Lert Park into a personalized sanctuary of complete wellbeing. Across three interconnected sanctums, the brand boldly presents a future-facing vision where the bathroom is liberated from purely functional expectation, evolving into an intentional multi-sensory space positively influencing human vitality.

Antoine Besseyre des Horts, Leader, LIXIL Global Design, Asia, commented, “Across Asia, high-end residential and hospitality properties need to address aspirations for deeply personal experiences. The GROHE SPA Aqua Sanctuary was created to meet these aspirations by leveraging the transformative power of water and demonstrating how spaces can be elevated into sensory retreats through tailored colors, materials, and finishes. The installation is designed around personalization and wellbeing – serving as an inspiration and a platform to converse and work together with the design community and industry partners to shape the present and future of personalized luxury.” 

The journey through the Aqua Sanctuary is articulated through three distinct sanctums: 

Sanctum 1: 

The first sanctum inspires with the futuristic Rainshower Icon 3D concept shower suspended as branches that mimic the forest and nature. The Oculus skyscape dynamically transitions from dawn to dusk, changing the mood from morning reset to evening release. The complementing GROHE SPA Icon 3D faucet and combination of water and light highlights how water-centric spatial design enhances the personal experience for calm and wellbeing.

Sanctum 2:

The second sanctum explores total visual continuity and collaboration, anchored by the GROHE SPA Atrio Private Collection featuring Caesarstone quartz handle accents. The space highlights the GROHE SPA x Buster + Punch partnership with a single, cohesive design language that harmonizes hardware, lighting and water in four striking finishes: Brushed Warm Sunset, Brushed Cool Sunrise, Supersteel, and Phantom Black. The collection empowers designers and homeowners to create fully coordinated, spa-like sanctuaries rooted in tailored wellbeing and timeless sophistication.

Sanctum 3: 

The third sanctum distills water into three distinct self-care rituals: Preparation, Relaxation, and Rejuvenation. Each space is customized with the GROHE SPA Allure Gravity collection in Phantom Black with Caesarstone Vanilla Noir details, modular Rainshower Aqua Tiles, and concealed Grohtherm control. The interchangeable glass and quartz cover plates allow designers to tailor each piece to its surrounding environment, while multiple mixer configurations and the full GROHE Colors range provide extraordinary flexibility. The result is a collection that becomes an integral design element—precise, sculptural, and uniquely personal.

The event also served as a thought leadership forum and industry exchange, featuring keynotes and panel discussion exploring the design and commercial trends shaping regional luxury hospitality and residential projects.

Audrey Yeo, Leader, LIXIL Water Technology APAC, shared, “In Asia Pacific’s high-end property sector, prestige is increasingly defined by how a space enhances personal wellbeing. GROHE SPA brings together modular design, precision craftsmanship and the finest materials and finishes to help designers and developers create highly personalized retreats. By reimagining the private master suite as an ‘Aqua Sanctuary’, we can transform an essential living space into a distinctive expression of luxury, strengthening both the customer experience and the property’s value without adding unnecessary complexity.” 

Architects, designers, and developers can access the complete GROHE SPA collections and dedicated specification support through LIXIL Experience Centers (LECs) and flagship showrooms across the region.

For further detailed product information and press materials, please see the following LINK.

Follow us on social media, on Facebook, Instagram, LinkedIn and YouTube.

About GROHE

GROHE is a leading global brand for complete bathroom solutions and kitchen fittings. Since 2014 GROHE has been part of the strong brand portfolio of LIXIL, a manufacturer of pioneering water and housing products. In order to offer “Pure Freude an Wasser”, every product is based on the brand values of quality, technology, design and sustainability.

The brand offers life-enhancing product solutions as well as services with its dedicated portfolios GROHE QuickFix, GROHE Professional and its luxury sub-brand GROHE SPA. All cater to the specific needs of GROHE’s professional business partners and their differentiated target groups.

With water at the core of its business, the brand contributes to LIXIL’s Impact Strategy with a resource-saving value chain: from CO₂-neutral* production, the removal of unnecessary plastic in the product packaging, all the way to water- and energy-saving product technologies such as GROHE Everstream, a water-recirculating shower.

About LIXIL

LIXIL (TSE Code 5938) makes pioneering water and housing products that solve everyday, real-life challenges, making better homes a reality for everyone, everywhere. Drawing on our Japanese heritage, we create world-leading technology and innovate to make high quality products that transform homes. But the LIXIL difference is how we do this; through meaningful design, an entrepreneurial spirit, a dedication to improving accessibility for all, and responsible business growth. Our approach comes to life through industry leading brands, including INAX, GROHE, American Standard, and TOSTEM. Approximately 53,000 colleagues operating in more than 150 countries are proud to make products that touch the lives of more than a billion people every day. Learn more at www.lixil.com

SINGAPORE, Sept. 28, 2026 /PRNewswire/ — Amber International Holding Limited (“Amber International” or the “Company”) (NASDAQ: AMBR), today announced that it will hold its 2026 annual general meeting on October 23, 2026 at 9:00 a.m. (Singapore time) or on October 22, 2026 at 9:00 p.m. (New York time) in Singapore.

Date:          October 23, 2026 (Singapore Time) or October 22, 2026 (New York Time)

Time:          09:00 a.m. (Singapore time) or 09:00 p.m. (New York Time)

Location:     1 Wallich Street, #30-02 Guoco Tower, Singapore                     

The annual general meeting will be devoted to the following proposals:

1. As a special resolution, to approve the grant of a one-off incentive share award to Mr. Michael Wu, consisting of an aggregate of 23,469,189 Class B ordinary shares, which shall be fully vested and issued on October 23, 2026, and all transactions contemplated thereby, including the issuance of such Class B ordinary shares pursuant thereto;
2. As an ordinary resolution, to approve and ratify the appointment of Mr. Michael Wu as a director and chairman of the board of directors of the Company;
3. As an ordinary resolution, to approve and ratify the appointment of Ms. Jie Jiao as an independent director of the Company;
4. As an ordinary resolution, to approve and ratify the appointment of Ms. Vicky Wang as a director of the Company;
5. As an ordinary resolution, to approve and ratify the appointment of Mr. Yi Bao as a director of the Company;
6. As an ordinary resolution, to approve and ratify the appointment of Ms. Noorsurainah Tengah as an independent director of the Company;
7. As an ordinary resolution, to approve and ratify the appointment of Mr. Daniel-Philippe Mamadou-Blanco as an independent director of the Company;
8. As an ordinary resolution, to confirm, approve and ratify the Company’s Post-IPO Share Incentive Plan, as amended and restated by the board of directors of the Company on May 16, 2025, including the increase of the share reserve to 11,000,000 Class A ordinary shares and the annual increase under Section 3.1 thereof; and
9. As an ordinary resolution, to act upon such other matters as may properly come before the Company’s annual general meeting or any adjournment or postponement thereof.

Only shareholders of record at the close of business on September 28, 2026 (New York Time) are entitled to receive notice of and to vote at the Company’s annual general meeting or any adjournment or postponement thereof.

The notice of the Company’s annual general meeting and the Company’s 2025 Annual Report containing the complete audited financial statements and the report of auditors for the year ended December 31, 2025 are available on the Investor Relations Section of the Company’s website at https://ir.ambr.io.

About Amber International Holding Limited

Amber International Holding Limited (Nasdaq: AMBR), is a technology company that builds specialized AI agents for high-value, high-stakes use cases. Drawing on deep domain expertise, trusted financial infrastructure, and experience serving sophisticated users, the Company develops agents that move beyond answering questions to understanding intent, maintaining context, and executing complex workflows on behalf of users. Its first two agents are in the market: Ambre, a consumer agent for personal finance, and MIA, an agent for growth and marketing workflows. Headquartered in Singapore, Amber International is listed on the Nasdaq Stock Market. For more information, visit https://ir.ambr.io.

HONG KONG, Sept. 28, 2026 /PRNewswire/ — PhotonPay, the next-generation financial operating system, today announced the launch of its local collection accounts in Nigeria and Ghana. This rollout enables global businesses to collect Nigerian naira (NGN) and Ghanaian cedi (GHS), providing a compliant and efficient channel for cross-border fund settlement across West Africa.

As global trade deepens its integration with high-growth regions, West Africa stands out as a critical hub for international expansion. According to the International Monetary Fund (IMF), Nigeria’s economic growth is projected at 4.1% in 2026, solidifying its position as an economic powerhouse driven by a massive consumer base and a rapidly scaling digital economy. Concurrently, Ghana is experiencing strong momentum. The country recorded a robust 6% GDP growth in the second quarter of 2026, tracked by Ghana Statistical Service. Together, these two markets form the commercial backbone of West Africa, offering significant opportunities for globally minded enterprises.

However, entering these markets often introduces complex operational friction. Cross-border fund flows into emerging markets can involve extended settlement cycles and elevated foreign exchange volatility, which create uncertainty in cost management and erode business margins. Account entity mismatches during international transfers can further trigger compliance reviews or risk-control blocks, delaying cash flows and straining trust between trading partners.

To resolve these settlement challenges, PhotonPay is expanding its emerging market infrastructure with local collection accounts in Nigeria and Ghana, working through established banking partnerships to optimize the flow of capital across both markets.

Key Benefits of PhotonPay’s Nigeria and Ghana Collection Accounts

• Local Accounts in Your Business Name

Businesses can open local collection accounts in Nigeria and Ghana under their own business names. Same-name matching ensures inbound funds align with local compliance requirements on both sides of the transaction.

• Collect Directly in NGN and GHS

Payments are received in local currency through domestic clearing networks. This removes the settlement lag introduced by cross-border routing and gives businesses cleaner control over what they actually receive.

• Accelerated Capital Flow

By routing collections through localized infrastructure, businesses can reduce conventional settlement delays, shortening the collection cycle from days to hours and dramatically improving working capital efficiency.

• Risk Management and FX Capabilities

PhotonPay’s AI-driven risk engine continuously monitors transactions to ensure strict regulatory compliance, while its FX capabilities empower businesses to mitigate currency volatility through automated, transparent conversions.

“To build a truly global enterprise today, companies need native financial connectivity in the exact markets where their next million buyers reside. Building upon our successful integration of local clearing networks in Kenya and South Africa, bringing Nigeria and Ghana into our ecosystem provides businesses with a formidable competitive advantage across the African continent. This deep, localized reach makes PhotonPay the definitive infrastructure for companies targeting emerging market expansion.”
— Chao, VP of Product, PhotonPay

As businesses increasingly look beyond traditional markets for new sources of growth, localized payment architecture will remain a decisive competitive advantage. With the strategic addition of Nigeria and Ghana to its global financial network, PhotonPay continues to bridge the gap between global ambition and local execution.

About PhotonPay

PhotonPay is a stablecoin-powered financial operating system built for global infrastructure. Designed for modern enterprises, PhotonPay enables businesses to send, receive, convert, and settle funds across both fiat and stablecoin rails through a single, compliance-first integration, spanning 200+ countries and territories.

For more information, visit [www.photonpay.com].

Disclaimer
This material is for general informational purposes only and does not constitute legal, regulatory, tax, accounting, or investment advice, nor an offer or solicitation for any product or service. The availability, features, and regulatory treatment of PhotonPay’s products and services may vary depending on the user’s location, business model, and the laws and regulations that apply. Any descriptions of functionality, performance, efficiency, cost savings, or compliance support (including, without limitation, references to “real–time”, “24/7”, “high-efficiency”, or “compliant” solutions) are aspirational or forward–looking in nature. Actual outcomes may differ due to market conditions, technological constraints, and regulatory developments, and PhotonPay makes no express or implied representation, warranty, or guarantee as to the achievement of any particular result.

– LNK001, an AND-gated CAR-T therapy targeting CAIX and ENPP3, is being evaluated in a Phase 1 study in advanced clear cell renal cell carcinoma at MD Anderson Cancer Center –

– Jie D’Elia, Ph.D., joins as Chief Executive Officer and Friedrich Graf Finckenstein, M.D., as Chief Medical Officer; co-founder Brian Slingerland becomes Executive Chair –

– Series A financing upsized from $60 million to $90 million to advance a second solid tumor program in colorectal cancer and expand the pipeline –

SOUTH SAN FRANCISCO, Calif. and AUSTIN, Texas, Sept. 28, 2026 /PRNewswire/ — Link Cell Therapies (“Link”), an oncology cell therapy company utilizing its proprietary logic-gating technology to develop next-generation CAR-T therapeutics for solid tumors and hematologic malignancies, today announced that it has initiated clinical dosing for its lead program, LNK001. The company also announced three additions to its executive leadership team and a $30 million expansion of its Series A financing.

Initiated clinical dosing of LNK001

LNK001 is being evaluated in a Phase 1 study in patients with advanced or metastatic clear cell renal cell carcinoma (“RCC”). Clinical dosing has begun at MD Anderson Cancer Center.

LNK001 requires the co-expression of two antigens, CAIX and ENPP3, which are both highly expressed in most RCC tumors. CAIX has long been among the most attractive targets in RCC, but conventional CAR-T cells directed against it have been limited by on-target, off-tumor toxicity in the biliary epithelium, where CAIX is also expressed. By gating CAR-T activity on both antigens, LNK001 is designed to preserve the antitumor potential of CAIX targeting while sparing the healthy tissue that has constrained single-antigen approaches.

LNK001 is manufactured at CTMC, a joint venture between Resilience and The University of Texas MD Anderson Cancer Center. Additional clinical trial details are available at https://clinicaltrials.gov/study/NCT07564232.

Leadership additions

Jie D’Elia, Ph.D., joins as Chief Executive Officer and a member of the Board of Directors. Dr. D’Elia was previously the CEO of SystImmune, Inc., a clinical-stage biopharmaceutical company focused on developing novel multi-specific antibodies and antibody-drug conjugates (“ADCs”). Before SystImmune, she spent eleven years at Bristol Myers Squibb (“BMS”), most recently as Senior Vice President of Business Development, Oncology, Hematology, and Cell Therapy. During her tenure at BMS, she made a significant impact to BMS’s pipeline evolution through multiple strategic partnerships and acquisitions in therapeutic areas ranging from oncology, hematology, cardiovascular, virology, and cell therapy. Prior to BMS, Dr. D’Elia served as the Vice President and Global Head of Business Development at Simcere Pharmaceutical, and held roles at AstraZeneca, Boston Consulting Group and Baxter Healthcare. Over the course of her career, she has led more than $40 billion in strategic partnerships and acquisitions. Dr. D’Elia holds a Ph.D. from the College of Pharmacy at the University of Texas at Austin and an MBA from Columbia Business School.

Brian Slingerland becomes Executive Chair. Brian co-founded Link in 2022 with Robbie Majzner, M.D., and Crystal Mackall, M.D., and has served on the Board of Directors. He previously co-founded and was the CEO of Stemcentrx, a next-generation ADC company that pursued novel targets with limited or no normal tissue expression, including DLL3 and SEZ6, and built the industry’s first end-to-end ADC GMP manufacturing facility. Abbvie acquired Stemcentrx in 2016 for $6.2 billion, which at the time was the largest private acquisition of all time in biotechnology. Prior to founding Stemcentrx, Brian was a Founding Partner at Qatalyst Partners and Vice President at Goldman Sachs where he helped companies raise private venture capital, execute IPOs and other financings, advised on mergers and acquisitions, and gained valuable experience working with CEOs at various stages of development. Brian has held other biotechnology CEO roles, including of recently acquired Convergent Genomics, and Everest Detection, and served on the Boards of Directors and provided initial capital to multiple biotech companies including Enliven Therapeutics. Brian is a graduate of Virginia Tech.

Friedrich Graf Finckenstein, M.D., joins as Chief Medical Officer. Dr Graf Finckenstein is a physician-scientist with decades of experience in clinical medicine, cancer research and drug development. Most recently, as Chief Medical Officer of Iovance Biotherapeutics he progressed the clinical portfolio of Tumor Infiltrating Lymphocyte (TIL) therapies across indications and next generation products and contributed to the approval of AMTAGVI^® (lifileucel) in the US, Canada and Australia as the first approved cell therapy for a solid tumor.  Before Iovance, he was Global Head of Oncology Translational Medicine at Roche Pharma Research and Early Development (pRED) in Basel, Switzerland. Earlier, he held clinical leadership roles at BMS, spanning early through late-stage development, including contributions to the approval of Opdivo^® (nivolumab) in lung cancer. He holds a medical degree from the University of Hamburg, is a board-certified pediatrician and has conducted laboratory cancer research at the Ludwig Institute, San Diego Branch, the Children’s Hospital Los Angeles and the University of Hamburg.

“From the beginning, our vision has been to translate this breakthrough science into therapies that can make a profound difference for people impacted by cancer,” said co-founder Robbie Majzner, M.D., of the Dana-Farber Cancer Institute and Harvard Medical School. “Bringing in leaders with the experience, commitment and passion to advance our technology and execute at scale gives me tremendous confidence that we can realize that vision.”

Abraham Bassan, Member of the Link Board of Directors and Partner at Samsara BioCapital, says “We are excited about the strength and depth of the leadership team at Link. Their broad experience and commitment to advancing our science puts the company in an excellent position to develop a new generation of impactful medicines for patients.”

Series A expansion to fund pipeline programs

Link’s previously announced $60 million Series A financing led by Johnson & Johnson, through its corporate venture capital organization, Johnson & Johnson Innovation – JJDC, Inc., with participation from founding investors Samsara BioCapital and Sheatree Capital, as well as Wing Venture Capital and new investors including BMS, Kyowa Kirin, Sherpa Healthcare Partners, Western Technology Investment and the MD Anderson Cancer Focus Fund, was upsized to $90 million.

The additional capital will support clinical and preclinical development of additional logic gated CAR-T programs. Link’s second solid tumor indication is colorectal cancer, where the company intends to begin a first-in-human trial in 2027 using a novel target pair co-expressed in the majority of colorectal tumors but absent from normal healthy tissues. Additional CAR-T programs in solid and hematologic cancers are in earlier development and will be advanced internally or through partnerships.

“Link’s logic-gate platform can make CAR-T broadly viable in solid tumors,” said Dr. D’Elia. “A targeting approach that reliably distinguishes tumor from healthy tissue is what allows CAR-T to pursue in solid tumors the kind of deep and durable responses it has achieved in hematologic cancers. This financing lets us advance a pipeline built on that approach across additional tumor types.”

About Link Cell Therapies

Link Cell Therapies (“Link”) is a biotechnology company based in South San Francisco, California, founded in 2022 by Robbie Majzner, M.D., and Crystal Mackall, M.D. at Stanford University, biotech entrepreneur Brian Slingerland, and Samsara BioCapital. Link’s proprietary logic-gating technology allows for safe targeting of multiple antigens that are co-expressed selectively on cancer cells, thereby reducing the risk of on-target, off-tumor toxicity. This enables discovery of an entirely new landscape of “clean” target pairs, and supports the development of next-generation CAR-T therapeutics for solid and hematologic cancers. Link’s team features industry-leading scientists collaborating with top-tier advisors and life science financial and strategic investors committed to improving outcomes for cancer patients. To learn more, please visit www.linkcelltx.com.

Media Contact

Link Cell Therapies
info@linkcelltherapies.com

Collaborations at CENTRESTAGE 2026 and Mid-Autumn K-Festival Week Highlight Integration of Technology, Fashion and Food

News Summary

• LG Electronics Hong Kong presented its home appliances at two major Korean cultural events this September.
• LG partnered with the Korea Trade-Investment Promotion Agency (KOTRA) at CENTRESTAGE to showcase how the LG Styler supports garment care in Korean fashion exhibits.
• During Mid-Autumn K-Festival Week, organized by the Korean Chamber of Commerce in Hong Kong, LG presented a “Housewarming by LG” K-Lifestyle experience zone featuring the LG Styler, InstaView™ refrigerator and multifunctional microwave steam oven.
• The events demonstrated how LG’s technologies can support convenient garment care and optimal food preservation in the daily lives of Hong Kong consumers.

HONG KONG, Sept. 28, 2026 /PRNewswire/ — LG Electronics (LG) Hong Kong highlighted its latest smart home technologies through two cultural collaborations in Hong Kong this September. Through its participation in CENTRESTAGE 2026 and Mid-Autumn K-Festival Week, LG demonstrated how its technologies – from garment-care and kitchen appliances to smart home solutions – can bring the creativity of Korean fashion and food culture to Hong Kong consumers, supporting more convenient everyday living.

Supporting K-Fashion Through Innovative Garment Care

At CENTRESTAGE 2026, held at the Hong Kong Convention and Exhibition Centre from Sept. 2-5, LG collaborated with the Korea Trade-Investment Promotion Agency (KOTRA) to support the Korea Pavilion. At the exhibition, the LG Styler provided a convenient garment-care solution for the fashion pieces on display, helping refresh and prepare them throughout the exhibition while reducing the need for frequent ironing that may place stress on delicate fabrics.

During the event, LG engaged with Korean fashion designer Antonio Shin, whose latest collection features delicate materials such as premium rayon and natural fibers. Shin emphasized that garment care is an integral part of extending the design vision and preserving a fabric’s unique character. He highlighted how the LG Styler’s steam technology helps refresh garments and maintain the original texture, drape and silhouette of delicate pieces, demonstrating how technology can complement a designer’s craftsmanship.

Creating a K-Lifestyle Experience at Mid-Autumn K-Festival Week

LG extended its efforts to share K-Lifestyle experiences at Mid-Autumn K-Festival Week from Sept. 21-27 at Central Market. The event, co-presented by the Korean Chamber of Commerce in Hong Kong (KoCham HK) and the Korea Agro-Fisheries & Food Trade Corporation, invited visitors to explore Korean culture through food, workshops and experiences.

LG hosted a dedicated “Housewarming by LG” K-Lifestyle experience zone to showcase a range of products, including the LG Styler and InstaView™ refrigerator. The interactive layout allowed visitors to experience firsthand how these appliances deliver comfort and convenience in a modern, welcoming home environment.

Showcasing K-Food and Ingredient Care

During a live cooking demonstration on Sept. 26, acclaimed Korean chef Park Joon-woo presented his interpretation of contemporary Korean cuisine using the LG 349L InstaView™ Bottom Freezer Refrigerator and the new LG 32L Multifunctional Microwave Steam Oven. Featuring Korean dishes such as Hanwoo beef with a galbijjim sauce and grilled Korean pork belly, Chef Park combined refined techniques and bold flavors to spotlight Korean culinary tradition and modern creativity.

During the demonstration, Chef Park highlighted the LG InstaView™ refrigerator’s Knock Twice feature, which illuminates the glass panel to let users see inside without opening the door. This helps to reduce cold-air loss and keep meal preparation more organized.

Chef Park also shared his culinary philosophy and discussed how careful organization and storage are equally important as quality ingredients. He noted that consistent temperature control is especially critical for preserving premium ingredients like Hanwoo beef and Handon pork. Supported by LG’s LinearCooling™ and DoorCooling⁺™ technologies, the refrigerator minimizes temperature fluctuations and circulates cool air evenly, helping ingredients maintain their freshness and flavor and giving home cooks greater confidence to elevate everyday dining.

Connecting Culture Through Technology

Through these collaborations, LG continues to create new connections between Korean creativity and Hong Kong consumers. Looking ahead, LG remains committed to integrating technology into everyday life, introducing more consumers to the convenience, style and sophistication of K-Lifestyle and the company’s Life’s Good brand vision.

About LG Electronics, Inc.

LG Electronics is a global innovator in technology and consumer electronics with a presence in almost every country and an international workforce of more than 74,000. LG’s four Companies – Home Appliance Solution, Media Entertainment Solution, Vehicle Solution and Eco Solution – combined for global revenue of over KRW 88 trillion in 2024. LG is a leading manufacturer of consumer and commercial products ranging from TVs, home appliances, air solutions, monitors, automotive components and solutions, and its premium LG SIGNATURE and intelligent LG ThinQ brands are familiar names world over. Visit www.LGnewsroom.com for the latest news.

About LG Electronics Home Appliance Solution Company

The LG Home Appliance Solution Company (HS) is a global leader in home appliances and AI home solutions. By leveraging industry-leading core technologies, the HS Company is committed to enhancing consumers’ quality of life and promoting sustainability. The company develops thoughtfully designed kitchen and living appliance solutions and has recently integrated LG’s Robot Business Division to incorporate advanced robot technologies into its home solutions. Together, these products offer enhanced convenience, exceptional performance, efficient operation and sustainable lifestyle solutions. For more news on LG, visit www.LG.com/global/newsroom/.